BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28840529)

  • 1. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
    Zhong Q
    AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
    Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W; Nokhodchi A
    Eur J Pharm Sci; 2015 Feb; 68():56-67. PubMed ID: 25497318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
    Zhong Q; da Rocha SR
    Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
    Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
    Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
    Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
    Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.
    Farkas DR; Hindle M; Longest PW
    Ann Biomed Eng; 2015 Nov; 43(11):2804-15. PubMed ID: 25986955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties.
    Liu C; Lin L; Huang Z; Wu Q; Jiang J; Lv L; Yu X; Quan G; Li G; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):85. PubMed ID: 30673901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols.
    Muralidharan P; Mallory EK; Malapit M; Phan H; Ledford JG; Hayes D; Mansour HM
    RSC Adv; 2020 Nov; 10(68):41846-41856. PubMed ID: 33391731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.